We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+12.17%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.02%
AUM
$394B
AUM Growth
+$44.6B
Cap. Flow
+$6.63B
Cap. Flow %
1.68%
Top 10 Hldgs %
19.2%
Holding
3,619
New
44
Increased
2,356
Reduced
681
Closed
81

Sector Composition

Rank Sector Weight
1 Technology 23.03%
2 Financials 12.41%
3 Healthcare 11.8%
4 Consumer Discretionary 10.03%
5 Industrials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLMD icon
3401
Relmada Therapeutics
RLMD
$477M
$51.8K ﹤0.01%
12,505
OPRT icon
3402
Oportun Financial
OPRT
$350M
$51K ﹤0.01%
13,044
-64,300
-83% -$275K
PFIE
3403
DELISTED
Profire Energy, Inc
PFIE
$50.1K ﹤0.01%
27,669
GAN
3404
DELISTED
GAN Ltd
GAN
$49.7K ﹤0.01%
31,476
ANIX icon
3405
Anixa Biosciences
ANIX
$110M
$49.6K ﹤0.01%
12,785
CYT
3406
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$48.6K ﹤0.01%
15,972
PSNL icon
3407
Personalis
PSNL
$1.5B
$48.2K ﹤0.01%
22,941
BNKK
3408
Bonk Inc
BNKK
$8.64M
$47.4K ﹤0.01%
+386
New +$36.3K
RSSS icon
3409
Research Solutions
RSSS
$70.9M
$47K ﹤0.01%
18,069
HGBL icon
3410
Heritage Global
HGBL
$37.2M
$46.7K ﹤0.01%
16,791
CATX icon
3411
Perspective Therapeutics
CATX
$363M
$46.6K ﹤0.01%
11,601
RAIN
3412
DELISTED
Rain Oncology Inc. Common Stock
RAIN
$46.6K ﹤0.01%
38,822
CVM icon
3413
CEL-SCI Corp
CVM
$26.6M
$44.8K ﹤0.01%
549
SPRB
3414
Spruce Biosciences
SPRB
$128M
$44.8K ﹤0.01%
204
FREE
3415
DELISTED
Whole Earth Brands, Inc. Class A Common Stock
FREE
$43.5K ﹤0.01%
12,768
YHGJ icon
3416
Yunhong Green CTI Ltd
YHGJ
$8.77M
$42.9K ﹤0.01%
2,021
GNSS icon
3417
Genasys
GNSS
$76.1M
$42.5K ﹤0.01%
20,918
SPRO icon
3418
Spero Therapeutics
SPRO
$71.2M
$42K ﹤0.01%
28,565
XBIT icon
3419
XBiotech
XBIT
$71M
$41.9K ﹤0.01%
10,477
LNSR icon
3420
LENSAR
LNSR
$74.1M
$41.6K ﹤0.01%
11,846
BDTX icon
3421
Black Diamond Therapeutics
BDTX
$120M
$40.7K ﹤0.01%
14,484
ATOS icon
3422
Atossa Therapeutics
ATOS
$23.6M
$40.4K ﹤0.01%
3,064
EGIO
3423
DELISTED
Edgio, Inc. Common Stock
EGIO
$40.1K ﹤0.01%
2,928
STXS icon
3424
Stereotaxis
STXS
$145M
$39.7K ﹤0.01%
22,696
AIOT
3425
PowerFleet Inc
AIOT
$381M
$38.9K ﹤0.01%
11,361

Similar funds

Charles Schwab's Q4 2023 Portfolio in Review

As of Q4 2023, Charles Schwab held 3,619 positions worth $394B, up 13% from $349B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Trading was light in Q4 2023: portfolio turnover was 3.5%. Charles Schwab opened 44 new positions and exited 81, leaving the 3,619-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.

  • Charles Schwab's largest Q4 2023 buy was Janus Henderson Mortgage-Backed Securities ETF: 7,612,323 shares worth $350M.
  • Charles Schwab added most to Merck in Q4 2023, an estimated $491M increase.
  • Charles Schwab's biggest Q4 2023 reduction was Novartis, cutting an estimated $409M.
  • Charles Schwab fully exited Activision Blizzard in Q4 2023, selling an estimated $343M.
  • Charles Schwab's ten largest holdings make up 19% of its $394B portfolio in Q4 2023.
  • Charles Schwab opened 44 new positions and closed 81 in Q4 2023.
  • Charles Schwab's portfolio value rose 13% quarter-over-quarter to $394B.

Based on Charles Schwab's 13F filing for Q4 2023, filed 6 Feb 2024.